Last reviewed · How we verify

NCT02471781

Zenith® TX2® Low Profile TAA Endovascular Graft

APPROVED FOR MARKETING Last updated 18 January 2020
What this trial tests

trial testing Zenith TX2 Low Profile TAA Endovascular Graft in Aortic Aneurysm. Approved for marketing.

Quick facts

Lead sponsorCook Group Incorporated
StatusAPPROVED FOR MARKETING
Study typeEXPANDED_ACCESS
Sites15 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Cook Group Incorporated

Who can join

18 and older, any sex, with Aortic Aneurysm or Penetrating Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Zenith TX2 Low Profile TAA Endovascular Graft extended study is to collect confirmatory safety and effectiveness data. The Zenith TX2 Low Profile TAA Endovascular Graft is indicated for the treatment of patients with a descending thoracic aortic aneurysm or penetrating ulcer and has an anatomy suitable for repair.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Hybrid repair versus conventional open repair for thoracic aortic arch aneurysms.
    Elhelali A, Hynes N, Devane D, Sultan S, et al · · 2021 · cited 13× · PMID 34085713 · DOI 10.1002/14651858.cd012923.pub2

Verify or expand the search:

Other recruiting trials for Aortic Aneurysm

Currently open trials in the same condition.

Other Cook Group Incorporated trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02471781.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing